Zacks.com on MSN
5 Biotech Stocks to Watch for Potential Upside
New drug approvals and encouraging pipeline progress should maintain momentum in the Zacks Biomedical and Genetics industry despite the uncertain macroeconomic environment. A strong portfolio and ...
And what a year it has been! Artificial intelligence is being incorporated into more aspects of our lives, weight-loss drugs ...
News-Medical.Net on MSN
Atelerix enters agreement with Cherry Biotech to integrate non-cryogenic transport solutions with advanced organoid models
Atelerix, a biotech company revolutionizing cell preservation and biological transport with its pioneering hydrogel ...
Explore the shipping of organoid models with Atelerix and Cherry Biotech's innovative collaboration for improved transport ...
An update from AI Technology Group ( ($AIPG) ) is now available. On December 15, 2025, AI Technology Group Inc., a company engaged in advanced ...
A 2025 report from a bipartisan, congressionally chartered commission warns that China is closing in on a win, and the United ...
GlobalData on MSN
Crescent and Kelun-Biotech swap cancer asset rights in double deal
The strategic partnership sees two separate financial deals for the pair of oncology assets. Rights to Kelun’s integrin ...
Jason P Rogers of James & Wells provides a guide to protecting pharmaceutical and biotech inventions in New Zealand, and previews the changes expected under proposed changes to the Patents Act In New ...
In the northwest corner of Sioux Falls, an 80-acre campus opened its first building this year dedicated entirely to expanding ...
Opportunities For Scientists The number of biotechnology patent applications filed in the United States has grown about 10 percent per year since 1990, reaching 15,600 for fiscal 1995. In contrast, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results